Wang Jufeng
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Irinotecan Plus Thalidomide in Second Line Advanced Gastric Cancer (NCT02401971) | Wang Jufeng | 2014-08-01 |
Track Wang Jufeng automatically
Every clearance here is in the API, with alerts when new ones post.